Taskaynatan H, Kucukzeybek Y, Yildiz Y, Salman T, Oflazoglu U, Varol U, et al. Low dose (d1-5/7) oral etoposide regimen in intensively treated platinum-resistant epithelial ovarian cancer: The İzmir oncology group (IZOG) study . Ann Med Res [Internet]. 2021 May 25 [cited 2026 Sep. 16];27(1):0029-33. Available from: http://www.annalsmedres.org/index.php/aomr/article/view/591